Alberto Puccini

CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.

Hideo Baba, Shivani Soni, H. Lenz, 2018, Cancer treatment reviews.

Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers

John L Marshall, P. Philip, R. Goldberg, 2018, Molecular Cancer Research.